Sensei biotherapeutics to participate in citi's 2023 virtual oncology leadership summit

Boston, feb. 16, 2023 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that company management will participate in a fireside chat at citi's 2023 virtual oncology leadership summit, on thursday, february 23rd at 11:00 a.m. et.
SNSE Ratings Summary
SNSE Quant Ranking